|
ASX - By Stock
|
ADX |
Re:
Ann: Welchau Gas Resources Upgrade
|
|
eieio
|
4 |
1.3K |
2 |
04/03/26 |
| 04/03/26 |
ASX - By Stock
|
4
|
1.3K
|
2
|
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB - a new dawn
|
|
eieio
|
3.2K |
1.3M |
0 |
27/11/25 |
| 27/11/25 |
ASX - By Stock
|
3.2K
|
1.3M
|
0
|
|
|
ASX - By Stock
|
EDE |
Re:
Ann: US Data Centre OptiBlend Orders Continue to Grow
|
|
eieio
|
27 |
8.4K |
12 |
27/10/25 |
| 27/10/25 |
ASX - By Stock
|
27
|
8.4K
|
12
|
|
|
ASX - By Stock
|
SNT |
Re:
Value of Syntara
|
|
eieio
|
390 |
119K |
3 |
05/07/25 |
| 05/07/25 |
ASX - By Stock
|
390
|
119K
|
3
|
|
|
ASX - By Stock
|
MSB |
Re:
MSB Shorts
|
|
eieio
|
881 |
277K |
4 |
22/06/25 |
| 22/06/25 |
ASX - By Stock
|
881
|
277K
|
4
|
|
|
ASX - By Stock
|
SNT |
Re:
Value of Syntara
|
|
eieio
|
390 |
119K |
7 |
20/06/25 |
| 20/06/25 |
ASX - By Stock
|
390
|
119K
|
7
|
|
|
ASX - By Stock
|
SNT |
Re:
Value of Syntara
|
|
eieio
|
390 |
119K |
5 |
19/06/25 |
| 19/06/25 |
ASX - By Stock
|
390
|
119K
|
5
|
|
|
ASX - By Stock
|
SNT |
Re:
Value of Syntara
|
|
eieio
|
390 |
119K |
13 |
14/05/25 |
| 14/05/25 |
ASX - By Stock
|
390
|
119K
|
13
|
|
|
ASX - By Stock
|
MOY |
Re:
MOY - claiming a tax loss, finding the necessary documents!
|
|
eieio
|
22 |
16K |
0 |
29/04/25 |
| 29/04/25 |
ASX - By Stock
|
22
|
16K
|
0
|
|
|
ASX - By Stock
|
NMG |
Re:
Buy and Sell Query
|
|
eieio
|
27 |
6.5K |
2 |
17/04/25 |
| 17/04/25 |
ASX - By Stock
|
27
|
6.5K
|
2
|
|
|
ASX - By Stock
|
XSO |
Re:
The Brains Trust - 2025
|
|
eieio
|
2.4K |
408K |
9 |
09/04/25 |
| 09/04/25 |
ASX - By Stock
|
2.4K
|
408K
|
9
|
|
|
ASX - By Stock
|
XSO |
Re:
PB's needs vs wants ratio...bottoming out. Sign of return of consumer optimism perhaps?
|
|
eieio
|
2 |
988 |
0 |
20/03/25 |
| 20/03/25 |
ASX - By Stock
|
2
|
988
|
0
|
|
|
ASX - By Stock
|
XSO |
PB's needs vs wants ratio...bottoming out. Sign of return of consumer optimism perhaps?
|
|
eieio
|
2 |
988 |
3 |
20/03/25 |
| 20/03/25 |
ASX - By Stock
|
2
|
988
|
3
|
|
|
ASX - By Stock
|
HYD |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
eieio
|
1 |
1.4K |
0 |
15/01/25 |
| 15/01/25 |
ASX - By Stock
|
1
|
1.4K
|
0
|
|
|
ASX - By Stock
|
RDM |
Re:
Ann: Sybella Conference Presentation
|
|
eieio
|
83 |
49K |
1 |
26/12/24 |
| 26/12/24 |
ASX - By Stock
|
83
|
49K
|
1
|
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
eieio
|
7.1K |
3.7M |
0 |
25/10/24 |
| 25/10/24 |
ASX - By Stock
|
7.1K
|
3.7M
|
0
|
|
|
ASX - By Stock
|
SPG |
Re:
Ann: Suspension from Quotation
|
|
eieio
|
10 |
7.0K |
3 |
23/09/24 |
| 23/09/24 |
ASX - By Stock
|
10
|
7.0K
|
3
|
|
|
ASX - By Stock
|
ALR |
Re:
Ann: High-Grade Copper and Gold Assays at Wee MacGregor
|
|
eieio
|
29 |
9.2K |
4 |
18/09/24 |
| 18/09/24 |
ASX - By Stock
|
29
|
9.2K
|
4
|
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
eieio
|
21K |
8.9M |
44 |
11/08/24 |
| 11/08/24 |
ASX - By Stock
|
21K
|
8.9M
|
44
|
|
|
ASX - By Stock
|
A1G |
Re:
Ann: Trading Halt
|
|
eieio
|
10 |
4.8K |
2 |
30/07/24 |
| 30/07/24 |
ASX - By Stock
|
10
|
4.8K
|
2
|
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Ethics Approval Broadens to All Topical Infections
|
|
eieio
|
17 |
6.1K |
6 |
24/06/24 |
| 24/06/24 |
ASX - By Stock
|
17
|
6.1K
|
6
|
|
|
ASX - By Stock
|
GGE |
GGE technicals
|
|
eieio
|
17 |
9.3K |
13 |
03/06/24 |
| 03/06/24 |
ASX - By Stock
|
17
|
9.3K
|
13
|
|
|
ASX - By Stock
|
SNT |
Program trading on a roll
|
|
eieio
|
0 |
508 |
3 |
29/05/24 |
| 29/05/24 |
ASX - By Stock
|
0
|
508
|
3
|
|
|
ASX - By Stock
|
MEI |
Re:
MEI chart
|
|
eieio
|
19 |
13K |
3 |
24/05/24 |
| 24/05/24 |
ASX - By Stock
|
19
|
13K
|
3
|
|
|
ASX - By Stock
|
MEI |
Re:
MEI chart
|
|
eieio
|
19 |
13K |
3 |
24/05/24 |
| 24/05/24 |
ASX - By Stock
|
19
|
13K
|
3
|
|
|
ASX - By Stock
|
MEI |
MEI chart
|
|
eieio
|
19 |
13K |
4 |
24/05/24 |
| 24/05/24 |
ASX - By Stock
|
19
|
13K
|
4
|
|
|
ASX - By Stock
|
RDN |
Re:
Daily Discussion
|
|
eieio
|
10K |
5.0M |
10 |
14/04/24 |
| 14/04/24 |
ASX - By Stock
|
10K
|
5.0M
|
10
|
|
|
ASX - By Stock
|
NGL |
Re:
NGL Chart
|
|
eieio
|
13 |
5.0K |
3 |
04/04/24 |
| 04/04/24 |
ASX - By Stock
|
13
|
5.0K
|
3
|
|
|
ASX - By Stock
|
RDM |
Re:
Sybella Benchmarking vs Peers
|
|
eieio
|
190 |
78K |
1 |
17/03/24 |
| 17/03/24 |
ASX - By Stock
|
190
|
78K
|
1
|
|
|
ASX - By Stock
|
ADX |
Re:
Ann: Welchau Gas Exploration Well Update - Report No 1
|
|
eieio
|
12 |
6.7K |
4 |
27/02/24 |
| 27/02/24 |
ASX - By Stock
|
12
|
6.7K
|
4
|
|
|
ASX - By Stock
|
NGL |
Re:
My Investment Thesis
|
|
eieio
|
30 |
11K |
3 |
21/02/24 |
| 21/02/24 |
ASX - By Stock
|
30
|
11K
|
3
|
|
|
ASX - By Stock
|
IVR |
Re:
Precious Metals should be in demand NOW
|
|
eieio
|
338 |
109K |
1 |
30/12/23 |
| 30/12/23 |
ASX - By Stock
|
338
|
109K
|
1
|
|
|
ASX - By Stock
|
IVR |
Re:
Precious Metals should be in demand NOW
|
|
eieio
|
338 |
109K |
2 |
29/12/23 |
| 29/12/23 |
ASX - By Stock
|
338
|
109K
|
2
|
|
|
ASX - By Stock
|
NVO |
Re:
Ann: Investor Presentation
|
|
eieio
|
7 |
2.9K |
3 |
11/11/23 |
| 11/11/23 |
ASX - By Stock
|
7
|
2.9K
|
3
|
|
|
ASX - By Stock
|
ARV |
Greatland Gold on the move
|
|
eieio
|
3 |
3.0K |
0 |
07/11/23 |
| 07/11/23 |
ASX - By Stock
|
3
|
3.0K
|
0
|
|
|
ASX - By Stock
|
ARV |
Re:
Ann: Board and Management Changes
|
|
eieio
|
39 |
17K |
4 |
05/11/23 |
| 05/11/23 |
ASX - By Stock
|
39
|
17K
|
4
|
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
eieio
|
21K |
8.9M |
8 |
30/10/23 |
| 30/10/23 |
ASX - By Stock
|
21K
|
8.9M
|
8
|
|
|
Political Debate
|
|
Re:
Sad day for Australia
|
|
eieio
|
468 |
78K |
3 |
15/10/23 |
| 15/10/23 |
Political Debate
|
468
|
78K
|
3
|
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Nature Cancer Publishes Results of PXS Garvin Collaboration
|
|
eieio
|
18 |
8.4K |
0 |
20/09/23 |
| 20/09/23 |
ASX - By Stock
|
18
|
8.4K
|
0
|
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Nature Cancer Publishes Results of PXS Garvin Collaboration
|
|
eieio
|
18 |
8.4K |
0 |
20/09/23 |
| 20/09/23 |
ASX - By Stock
|
18
|
8.4K
|
0
|
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Nature Cancer Publishes Results of PXS Garvin Collaboration
|
|
eieio
|
18 |
8.4K |
1 |
20/09/23 |
| 20/09/23 |
ASX - By Stock
|
18
|
8.4K
|
1
|
|
|
ASX - By Stock
|
ARV |
Unusual trading
|
|
eieio
|
71 |
31K |
3 |
19/06/23 |
| 19/06/23 |
ASX - By Stock
|
71
|
31K
|
3
|
|
|
ASX - By Stock
|
A4N |
Re:
Ann: Expansion of Synthetic Sapphire Glass Agreements with Ebner
|
|
eieio
|
7 |
3.5K |
0 |
05/06/23 |
| 05/06/23 |
ASX - By Stock
|
7
|
3.5K
|
0
|
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Becoming a substantial holder
|
|
eieio
|
87 |
52K |
4 |
03/05/23 |
| 03/05/23 |
ASX - By Stock
|
87
|
52K
|
4
|
|
|
ASX - By Stock
|
MTH |
Re:
Ann: Quarterly Activities Report and Appendix 5B
|
|
eieio
|
11 |
6.1K |
3 |
03/05/23 |
| 03/05/23 |
ASX - By Stock
|
11
|
6.1K
|
3
|
|
|
ASX - By Stock
|
FRX |
Re:
Ann: Flexiroam extends CEO's Employment Agreement
|
|
eieio
|
25 |
8.3K |
0 |
02/04/23 |
| 02/04/23 |
ASX - By Stock
|
25
|
8.3K
|
0
|
|
|
ASX - By Stock
|
FRX |
Re:
Ann: Response to ASX Price and Volume Query
|
|
eieio
|
15 |
5.5K |
0 |
02/03/23 |
| 02/03/23 |
ASX - By Stock
|
15
|
5.5K
|
0
|
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MESOBLAST CURES SR-aGVHD IN CHILDREN
|
|
eieio
|
81 |
41K |
36 |
23/02/23 |
| 23/02/23 |
ASX - By Stock
|
81
|
41K
|
36
|
|
|
ASX - By Stock
|
FRX |
Re:
Ann: Quarterly Update and Appendix 4C - December 2022
|
|
eieio
|
14 |
5.0K |
1 |
17/01/23 |
| 17/01/23 |
ASX - By Stock
|
14
|
5.0K
|
1
|
|
|
ASX - By Stock
|
FRX |
Re:
Ann: Quarterly Update and Appendix 4C - December 2022
|
|
eieio
|
14 |
5.0K |
0 |
17/01/23 |
| 17/01/23 |
ASX - By Stock
|
14
|
5.0K
|
0
|
|